Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Josh LaBaer in as New President of US HUPO and More

Premium

Joshua LaBaer, director of the Virginia G. Piper Center for Personalized Diagnostics and chair of the Biodesign Institute directorate at Arizona State University, has been named president of the US Human Proteome Organization. LaBaer formerly was director of the Harvard Institute of Proteomics.


CombiMatrix this week announced that Richard Hockett will be the company's new medical director starting May 1.

Hockett was previously the chief medical officer of Affymetrix.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.